GLP-1 Drugs Weight Loss List: What Each One Is

Maybe a friend mentioned a weekly injection, a headline kept popping up in your feed, or a relative started a new prescription, and now you are trying to sort the brand names from the generic ones. The names are confusing because some share the same active ingredient but are sold under different brands for different conditions. A GLP-1 drugs weight loss list generally includes semaglutide, liraglutide, and tirzepatide, which are prescription medicines whose use is decided by a licensed clinician.

What medications usually appear on a GLP-1 weight loss list?

Three white cotton napkins, folded in different ways, rest on a blue outdoor table in soft daylight.

Most lists center on a small group of prescription medicines that act on gut hormone pathways involved in appetite and blood sugar. According to the U.S. Food and Drug Administration (FDA), several products in this family are approved for chronic weight management in certain adults, while others are approved mainly for type 2 diabetes. The same active ingredient can appear under more than one brand name, which is why lists can look longer than they really are.

Semaglutide

Semaglutide is sold under different brand names, with some versions labeled for diabetes and others for weight management. Some forms are given as an injection and one form is taken by mouth for diabetes. Which version is appropriate is a prescriber's decision, not something to guess from a brand name.

Liraglutide

Liraglutide is an older member of the family and is also marketed under separate brand names for diabetes and for weight management. It is generally given by injection. Because it has been available longer, clinicians often have more experience with it, though that does not make it right for everyone.

Tirzepatide

Tirzepatide is often grouped with GLP-1 drugs in everyday conversation, but it acts on two hormone pathways rather than one. FDA labeling describes separate products for diabetes and for weight management. Strictly speaking, it is a "dual" agonist, so some sources list it beside the GLP-1 group rather than inside it.

Other names you may see

Older or less commonly discussed medicines in related classes, such as exenatide or dulaglutide, sometimes appear on broad lists. These are mainly labeled for type 2 diabetes rather than weight management. A list that mixes diabetes-only products with weight-management products can be misleading, so it helps to check what each one is actually approved for.

Another point worth knowing: you may also come across compounded or "knockoff" versions sold online. The FDA has issued general public warnings about unapproved and compounded versions of these medicines, so it is wise to discuss sourcing with a pharmacist or clinician.

How do these medications differ from one another?

According to FDA drug labeling, products with the same ingredient can carry different brand names and different approved uses. That is why "same drug, different label" is common in this space.

Here are the differences people most often ask about:

Approved purpose: Some products are labeled for chronic weight management, others for type 2 diabetes, and a few for both in separate versions.
Form: Most are injections, while at least one is an oral tablet for diabetes. The way a product is given is set by its labeling and the prescriber.
Mechanism: Some act on one hormone pathway and others on two, which is part of why clinicians discuss them separately.
Schedule and amounts: These are determined by the prescriber and the product label, often adjusted gradually. Questions about amounts belong with a clinician or pharmacist.

Common side effects described in FDA labeling and in MedlinePlus general information include digestive reactions such as nausea, vomiting, diarrhea, or constipation. Reactions vary from person to person, and some people find them manageable while others do not. Labels also describe rarer, more serious concerns, so anyone considering these medicines should read the official medication guide and talk it through with a professional.

One honest limitation: these medicines are not a standalone solution. Guidance from the National Institutes of Health (NIH) generally frames medication as one part of a broader plan that includes eating patterns, physical activity, sleep, and ongoing follow-up. Results differ between people, and weight can change again if treatment stops.

Who may not be a good fit, and what should you ask a clinician?

These medicines are generally not meant for casual or cosmetic use, and certain medical histories can make them a poor match. FDA labeling lists situations where caution or avoidance applies, such as a personal or family history of certain thyroid tumors, pregnancy or plans to become pregnant, and some pancreatic or gallbladder conditions. A clinician reviews that history before anything is prescribed.

Eligibility for weight-management products is usually tied to body mass index and related health conditions, based on the product's approved labeling. The exact thresholds are on the label and are applied by a prescriber. Someone who falls outside those criteria may still have other options worth discussing.

Certain groups deserve extra care and a more detailed conversation. These include people who take other diabetes medicines, those with kidney or digestive problems, and anyone with a history of disordered eating. Because these medicines affect appetite, a clinician may want to think carefully about how they fit with someone's relationship with food.

Useful questions to bring to an appointment include:

Which product, if any, matches my health history and goals?
What side effects should I watch for, and when should I call you?
How will we monitor progress and decide whether to continue?
What happens to my plan if I stop or if supply is interrupted?
How does this fit with my other medicines and supplements?
What nutrition and activity support is available alongside it?

Seek prompt medical care if you notice severe or persistent abdominal pain, repeated vomiting, signs of dehydration, or symptoms of an allergic reaction. Product labeling and the FDA describe these as reasons to contact a healthcare professional. If something feels seriously wrong, emergency services are the right call rather than waiting for an appointment.

Frequently asked questions

Is tirzepatide technically a GLP-1 drug?

Tirzepatide acts on two hormone pathways, one of which is the GLP-1 pathway, so it is often grouped with this class in casual lists. If you want a strict definition, some sources call it a dual agonist rather than a pure GLP-1 drug. Either way, its approved uses are set out in FDA labeling.

Why do some lists include diabetes-only medicines?

Lists that blend products often include medicines in the same family that are labeled mainly for type 2 diabetes. If a product is labeled only for diabetes, it is not the same as one approved for chronic weight management. Checking each product's FDA labeling shows which use it is approved for.

Can I buy these medicines online without a prescription?

If a website offers these medicines with no prescription or clinical review, that is a reason for caution. The FDA has issued general public warnings about unapproved and compounded versions sold online. A pharmacist or clinician can help you understand how to obtain a product through a legitimate channel.

References

U.S. Food and Drug Administration (FDA), drug labeling and consumer information on weight management and diabetes medicines
MedlinePlus, general medication information for this drug class
National Institutes of Health (NIH), general guidance on weight management

Whether a prescription medicine or a specific dose is right for you is a decision to make with a doctor or pharmacist.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a licensed professional for personal health decisions.